← Back to catalogue

ACCUJECT 2.1-1P Injector Set

EUDAMEDFDA 510(k)

Class IIa (EU MDR)

Ref LP604590Model IOL injectors

by Medicel AG

Identity

Trade Name
ACCUJECT 2.1-1P Injector Set EUDAMED
Device Name
IOL injectors EUDAMED
Model / Reference
IOL injectors EUDAMED
LP604590 EUDAMED

Identifiers

Primary DI / UDI-DI
07630055214027 EUDAMED
07630055214652 EUDAMED
07630055212368 EUDAMED
07630055214591 EUDAMED
07630055214584 EUDAMED
Basic UDI-DI
076300552INJ01YD EUDAMED
Direct Marketing DI
07630055214652 EUDAMED
07630055212368 EUDAMED
07630055214591 EUDAMED
EMDN Code
Q021111 OCULAR IMPLANT INSTRUMENTS, SINGLE-USE EUDAMED

Classification

Device Class
Class IIa EUDAMED
Market of Registration
Germany EUDAMED

Clinical & Handling

Sterile

Yes

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

ACCUJECT 2.1-1P Injector Set by Medicel AG — Class IIa — FDA_510K, MDR — listed in EUDAMED, FDA 510(k) — regulatory data on deviCERTS

Authorization Coverage (2 countries)

Regulatory Authorizations

United States Active

FDA_510K

European Union Active

CE/MDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Medicel AG
EUDAMED SRN
CH-MF-000016652
Authorised Representative
Rudolf Riester GmbH DE-AR-000015844

Sources (6)

  • EUDAMED ed2b870e-b47e-41f6-a175-e328bd9e19eb 61 fields · synced Oct 6, 2026
  • EUDAMED 7678413e-f0a0-45dd-9fb3-ee2b15d0de46 61 fields · synced May 17, 2026
  • EUDAMED ee3b833a-6e1a-424b-a891-33721b3ada22 61 fields · synced May 18, 2026
  • EUDAMED 5aaaedfd-dc81-48d9-954d-a4046919771d 61 fields · synced May 19, 2026
  • EUDAMED 7fbf1e93-3e76-4d48-9e20-88e1e7324cf8 61 fields · synced May 19, 2026
  • FDA 510(k) K252540 1 fields · synced May 18, 2026